3-(4-carboxybenzoyl)-2-quinolinecarboxaldehyde has been researched along with tobramycin in 1 studies
Studies (3-(4-carboxybenzoyl)-2-quinolinecarboxaldehyde) | Trials (3-(4-carboxybenzoyl)-2-quinolinecarboxaldehyde) | Recent Studies (post-2010) (3-(4-carboxybenzoyl)-2-quinolinecarboxaldehyde) | Studies (tobramycin) | Trials (tobramycin) | Recent Studies (post-2010) (tobramycin) |
---|---|---|---|---|---|
30 | 0 | 7 | 4,902 | 629 | 1,205 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abdullah, A; DiCicco, M; Goldfinger, A; Guirand, F; Jansen, SA | 1 |
1 other study(ies) available for 3-(4-carboxybenzoyl)-2-quinolinecarboxaldehyde and tobramycin
Article | Year |
---|---|
In vitro tobramycin elution analysis from a novel beta-tricalcium phosphate-silicate-xerogel biodegradable drug-delivery system.
Topics: Anti-Bacterial Agents; Benzoates; Biocompatible Materials; Bone Substitutes; Calcium Carbonate; Calcium Phosphates; Drug Delivery Systems; Gels; Humans; Hydroxyapatites; Materials Testing; Molecular Structure; Osteomyelitis; Quinolines; Reproducibility of Results; Silicates; Tobramycin | 2004 |